Hospital
Pineville Community Health Center INC
Pineville Community Health Center INC was paid $3.65M by Medicaid between Oct 2019 and Dec 2024, across 99 billing codes. Its largest line is 99283, emergency room visit (moderate) — 25% of everything it billed.
33Billing provider infoPINEVILLE COMMUNITY HEALTH CENTER INC
PINEVILLE, KY 40977
PINEVILLE, KY 40977
33aNPI1285292219assigned 06/04/2019
33bProvider typeGeneral Acute Care Hospital
28Total paid$3.65M
24GClaims127,404
24DCodes billed99
24AFirst – last monthOct 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Kentucky
Rank by total paid#32 of 36
Median peer was paid$36.08M
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 5,725 | $80K | |
| 2020 | 27,963 | $421K | |
| 2021 | 33,232 | $600K | |
| 2022 | 23,599 | $625K | |
| 2023 | 18,458 | $727K | |
| 2024incomplete | 18,427 | $1.20M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 25% | 7,754 | 5,738 | $897K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 4,195 | 2,738 | $640K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.7% | 2,770 | 1,008 | $354K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 5.9% | 1,399 | 854 | $215K |
| G0378 | Hospital observation service, per hour | 4.1% | 544 | 374 | $150K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.1% | 738 | 484 | $115K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.0% | 3,835 | 2,649 | $110K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.0% | 1,312 | 1,076 | $109K |
| 71046 | Radiologic examination, chest; 2 views | 2.7% | 5,395 | 3,210 | $98K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 2.6% | 3,869 | 3,020 | $96K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.5% | 2,836 | 1,116 | $93K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.9% | 847 | 320 | $71K |
87 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 2,878 | $67K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.7% | 2,659 | $61K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 20,755 | $56K |
| 80053 | Comprehensive metabolic panel | 1.4% | 9,206 | $51K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 10,640 | $43K |
| 86328 | 1.1% | 1,550 | $40K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.1% | 1,304 | $39K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,218 | $34K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,586 | $32K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,946 | $24K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 336 | $23K |
| 80061 | Lipid panel | <1% | 2,568 | $17K |
| 84484 | <1% | 2,750 | $17K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,106 | $16K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 817 | $16K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,665 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,550 | $13K |
| 87430 | <1% | 1,177 | $12K | |
| 72100 | <1% | 379 | $11K | |
| 82607 | <1% | 1,015 | $8K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 203 | $6K |
| 84439 | <1% | 1,235 | $6K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 173 | $5K |
| 94664 | <1% | 391 | $5K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 305 | $5K |
| 84703 | <1% | 1,009 | $4K | |
| 83690 | <1% | 1,211 | $4K | |
| 86769 | <1% | 161 | $4K | |
| 81001 | <1% | 2,437 | $4K | |
| 76536 | <1% | 74 | $4K | |
| 73562 | <1% | 185 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 66 | $4K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,361 | $3K |
| 83735 | <1% | 1,008 | $3K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 706 | $3K |
| 83550 | <1% | 742 | $3K | |
| 82550 | <1% | 746 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 15 | $3K |
| 83540 | <1% | 783 | $3K | |
| 73610 | <1% | 65 | $2K | |
| 73030 | <1% | 132 | $2K | |
| 83605 | <1% | 325 | $2K | |
| 73630 | <1% | 82 | $2K | |
| 72040 | <1% | 114 | $2K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 538 | $2K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 510 | $2K |
| 73130 | <1% | 67 | $2K | |
| 74018 | <1% | 48 | $2K | |
| 87420 | <1% | 192 | $2K | |
| 87040 | <1% | 227 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,790 | $1K |
| 84436 | <1% | 335 | $1K | |
| 84550 | <1% | 406 | $1K | |
| 85610 | <1% | 229 | $954.52 | |
| 81003 | <1% | 794 | $883.10 | |
| 85379 | <1% | 193 | $850.50 | |
| 74022 | <1% | 22 | $762.99 | |
| 72070 | <1% | 35 | $679.89 | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 15 | $638.16 |
| J2704 | Injection, propofol, 10 mg | <1% | 314 | $628.11 |
| 82150 | <1% | 189 | $604.21 | |
| 82948 | <1% | 232 | $550.62 | |
| 0012A | <1% | 44 | $506.53 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 19 | $497.26 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 255 | $479.95 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 344 | $438.50 |
| 85652 | <1% | 351 | $424.09 | |
| 73502 | <1% | 21 | $380.45 | |
| 83880 | <1% | 24 | $353.36 | |
| 72110 | <1% | 15 | $337.09 | |
| 80320 | <1% | 16 | $335.15 | |
| 0011A | <1% | 41 | $296.18 | |
| 85730 | <1% | 91 | $257.93 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 210 | $231.84 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 55 | $125.61 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 23 | $110.57 |
| 84153 | <1% | 20 | $104.22 | |
| 82728 | <1% | 15 | $99.63 | |
| J1956 | Injection, levofloxacin, 250 mg | <1% | 29 | $99.55 |
| 87186 | <1% | 38 | $95.15 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 171 | $94.35 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 78 | $64.02 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 25 | $48.68 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 165 | $40.29 |
| 87205 | <1% | 21 | $40.13 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 34 | $32.98 |
| 81015 | <1% | 35 | $7.32 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRICHTER, SHERYL (PRESIDENT/CEO)
| Provider | Location | Paid |
|---|---|---|
| Pineville Community Health Center INC | Pineville, KY | $7.49M |
| Pineville Community Hospital Association, INC. | Pineville, KY | $59K |
| Pineville Community Health Center INC | Pineville, KY | $10K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.